A randomized, double-blind, placebo-controlled trial was designed to test the ability of Probiotic-3 to reduce symptoms associated with acute infectious diarrhea. The study focused on 304 children between three months and six years of age admitted to a primary care centre with viral or bacterial infections. Duration of diarrhea was 30% shorter in children receiving Probiotic-3 and was associated with a 30% shorter hospital stay.
Chen, C. C., Kong, M. S., Lai, M. W., Chao, H. C., Chang, K. W., Chen, S. Y., Huang, Y. C., Chiu, C. H., Li, W. C., Lin, P. Y., Chen, C. J., & Li, T. Y. (2010). The Pediatric infectious disease journal, 29(2), 135–138. https://doi.org/10.1097/inf.0b013e3181b530bf